Pharmigene, Inc.

Pharmigene, Inc.verified

7595.TWO

Price:

$10.4

Market Cap:

$524.90M

Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally. It offers molecular diagnostics to test adverse drug reactions; and DNA extraction products for gene expression analysis, clinical molecular diagnosis, human identity testing, forensics, and biomedical research applications. The company also provides pharmacogenomics test, drug allergy test, and functional medicine test services. In addition, it distributes various genomics and genetics equipment and reagents; and provides professional consultation, training program, analysis software, and technical support solutions. Further, the company offers CDMO services. The company was founded i...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-12-22

Stock Exchange

TWO

Ticker

7595.TWO

The Enterprise Value as of December 2025 (TTM) for Pharmigene, Inc. (7595.TWO) is 1.11B

According to Pharmigene, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.11B. This represents a change of -17.24% compared to the average of 1.34B of the last 4 quarters.

Pharmigene, Inc. (7595.TWO) Historical Enterprise Value (quarterly & annually)

How has 7595.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Pharmigene, Inc. over the last ten years is 912.99M. The current 1.11B Enterprise Value has changed 12.02% with respect to the historical average. Over the past ten years (40 quarters), 7595.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 1.56B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

912.99M

Median

809.29M

Minimum

510.48M

Maximum

1.46B

Pharmigene, Inc. (7595.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pharmigene, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 87.16%

Maximum Annual Enterprise Value = 1.46B

Minimum Annual Increase = -14.61%

Minimum Annual Enterprise Value = 510.48M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.24B-14.61%
20231.46B87.16%
2022777.97M-7.45%
2021840.60M29.41%
2020649.56M27.24%

Pharmigene, Inc. (7595.TWO) Average Enterprise Value

How has 7595.TWO Enterprise Value performed in the past?

The current Enterprise Value of Pharmigene, Inc. (7595.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.16B

5-year avg

993.49M

10-year avg

912.99M

Pharmigene, Inc. (7595.TWO) Enterprise Value vs. Peers

How is 7595.TWO’s Enterprise Value compared to its peers?

Pharmigene, Inc.’s Enterprise Value is greater than UniPharma Co., Ltd. (394.47M), greater than Taiwan Advanced Nanotech Inc. (634.94M), greater than DuoGenic StemCells corporation (680.91M), greater than Sunder Biomedical Tech. Co., Ltd. (754.71M), greater than A-SPINE Asia Co., Ltd. (612.88M), greater than Bioray Biotech Co., Ltd (502.94M), greater than Health & Life Co., Ltd. (546.95M), greater than Welgene Biotech Co.,Ltd. (407.30M), greater than Original BioMedicals Co., Ltd. (840.74M), greater than Vectorite Biomedical Inc. (599.37M),

Build a custom stock screener for Pharmigene, Inc. (7595.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmigene, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmigene, Inc. (7595.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmigene, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pharmigene, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Pharmigene, Inc. (7595.TWO)?

What is the 3-year average Enterprise Value for Pharmigene, Inc. (7595.TWO)?

What is the 5-year average Enterprise Value for Pharmigene, Inc. (7595.TWO)?

How does the current Enterprise Value for Pharmigene, Inc. (7595.TWO) compare to its historical average?